168 related articles for article (PubMed ID: 37486445)
21. PPV and Detection Rate of mt-sDNA Testing, FIT, and CT Colonography for Advanced Neoplasia: A Hierarchic Bayesian Meta-Analysis of the Noninvasive Colorectal Screening Tests.
Pickhardt PJ; Correale L; Hassan C
AJR Am J Roentgenol; 2021 Oct; 217(4):817-830. PubMed ID: 33703913
[No Abstract] [Full Text] [Related]
22. Healthcare costs, resource utilization, and productivity loss associated with colorectal cancer screening.
Engel-Nitz NM; Miller-Wilson LA; Le L; Fisher DA
Expert Rev Pharmacoecon Outcomes Res; 2023; 23(7):843-852. PubMed ID: 37462667
[TBL] [Abstract][Full Text] [Related]
23. Multi-Target Stool DNA Testing for Colorectal Cancer Screening: Emerging Learning on Real-world Performance.
Eckmann JD; Ebner DW; Kisiel JB
Curr Treat Options Gastroenterol; 2020 Mar; 18(1):109-119. PubMed ID: 31965446
[TBL] [Abstract][Full Text] [Related]
24. Cost-Effectiveness of Multitarget Stool DNA Testing vs Colonoscopy or Fecal Immunochemical Testing for Colorectal Cancer Screening in Alaska Native People.
Redwood DG; Dinh TA; Kisiel JB; Borah BJ; Moriarty JP; Provost EM; Sacco FD; Tiesinga JJ; Ahlquist DA
Mayo Clin Proc; 2021 May; 96(5):1203-1217. PubMed ID: 33840520
[TBL] [Abstract][Full Text] [Related]
25. What do 'false-positive' stool tests really mean? Data from the New Hampshire colonoscopy registry.
Butterly LF; Hisey WM; Robinson CM; Limburg PJ; Kneedler BL; Anderson JC
Prev Med Rep; 2023 Oct; 35():102309. PubMed ID: 37449002
[TBL] [Abstract][Full Text] [Related]
26. Alaska Native Patient and Provider Perspectives on the Multitarget Stool DNA Test Compared With Colonoscopy for Colorectal Cancer Screening.
Redwood DG; Blake ID; Provost EM; Kisiel JB; Sacco FD; Ahlquist DA
J Prim Care Community Health; 2019; 10():2150132719884295. PubMed ID: 31646933
[No Abstract] [Full Text] [Related]
27. Diagnostic Performance of Multitarget Stool DNA and CT Colonography for Noninvasive Colorectal Cancer Screening.
Pickhardt PJ; Graffy PM; Weigman B; Deiss-Yehiely N; Hassan C; Weiss JM
Radiology; 2020 Oct; 297(1):120-129. PubMed ID: 32779997
[TBL] [Abstract][Full Text] [Related]
28. Three-Year Interval for the Multi-Target Stool DNA Test for Colorectal Cancer Screening: A Longitudinal Study.
Imperiale TF; Lavin PT; Marti TN; Jakubowski D; Itzkowitz SH; May FP; Limburg PJ; Sweetser S; Daghestani A; Berger BM
Cancer Prev Res (Phila); 2023 Feb; 16(2):89-97. PubMed ID: 36205504
[TBL] [Abstract][Full Text] [Related]
29. Evaluating Outreach Methods for Multi-Target Stool DNA Test for Colorectal Cancer Screening Among an Employer Population.
Shepherd ME; Lecorps A; Harris-Shapiro J; Miller-Wilson LA
J Prim Care Community Health; 2021; 12():21501327211037892. PubMed ID: 34382887
[TBL] [Abstract][Full Text] [Related]
30. Multitarget stool DNA testing for the prevention of colon cancer: outcomes in a large integrated healthcare system.
Vakil N; Ciezki K; Huq N; Singh M
Gastrointest Endosc; 2020 Aug; 92(2):334-341. PubMed ID: 31904379
[TBL] [Abstract][Full Text] [Related]
31. Early Adoption of a Multitarget Stool DNA Test for Colorectal Cancer Screening.
Finney Rutten LJ; Jacobson RM; Wilson PM; Jacobson DJ; Fan C; Kisiel JB; Sweetser S; Tulledge-Scheitel SM; St Sauver JL
Mayo Clin Proc; 2017 May; 92(5):726-733. PubMed ID: 28473037
[TBL] [Abstract][Full Text] [Related]
32. Robust performance of a novel stool DNA test of methylated SDC2 for colorectal cancer detection: a multicenter clinical study.
Wang J; Liu S; Wang H; Zheng L; Zhou C; Li G; Huang R; Wang H; Li C; Fan X; Fu X; Wang X; Guo H; Guan J; Sun Y; Song X; Li Z; Mu D; Sun J; Liu X; Qi Y; Niu F; Chen C; Wu X; Wang X; Song X; Zou H
Clin Epigenetics; 2020 Oct; 12(1):162. PubMed ID: 33126908
[TBL] [Abstract][Full Text] [Related]
33. Positive Predictive Value for Multitarget Stool DNA After Bariatric and Metabolic Surgery.
Ebner DW; Burger KN; Broderick B; Mahoney DW; Kellogg TA; Acosta A; Kisiel JB
Gastro Hep Adv; 2023; 2(7):902-910. PubMed ID: 37876832
[TBL] [Abstract][Full Text] [Related]
34. Real-world cost-effectiveness of stool-based colorectal cancer screening in a Medicare population.
Fisher DA; Karlitz JJ; Jeyakumar S; Smith N; Limburg P; Lieberman D; Fendrick AM
J Med Econ; 2021; 24(1):654-664. PubMed ID: 33902366
[TBL] [Abstract][Full Text] [Related]
35. A novel multitarget stool DNA test for colorectal cancer screening.
Malik P
Postgrad Med; 2016; 128(2):268-72. PubMed ID: 26753807
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic Accuracy of Stool Tests for Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors.
Ykema B; Rigter L; Spaander M; Moons L; Bisseling T; Aleman B; de Boer JP; Lugtenburg P; Janus C; Petersen E; Roesink J; Raemaekers J; van der Maazen R; Lansdorp-Vogelaar I; Gini A; Verbeek W; Lemmens M; Meijer G; van Leeuwen F; Snaebjornsson P; Carvalho B; van Leerdam M
J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31936745
[TBL] [Abstract][Full Text] [Related]
37. Specificity of the Multi-Target Stool DNA Test for Colorectal Cancer Screening in Average-Risk 45-49 Year-Olds: A Cross-Sectional Study.
Imperiale TF; Kisiel JB; Itzkowitz SH; Scheu B; Duimstra EK; Statz S; Berger BM; Limburg PJ
Cancer Prev Res (Phila); 2021 Apr; 14(4):489-496. PubMed ID: 33436397
[TBL] [Abstract][Full Text] [Related]
38. Inappropriate Multi-Target Stool DNA Use for Colorectal Cancer Screening: Risks, Compliance, and Outcomes.
Lazar NJ; Khreisat A; AlKloub R; Al-Hillan A; Duffy M
Cureus; 2023 Jun; 15(6):e40506. PubMed ID: 37397671
[TBL] [Abstract][Full Text] [Related]
39. Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia.
Lidgard GP; Domanico MJ; Bruinsma JJ; Light J; Gagrat ZD; Oldham-Haltom RL; Fourrier KD; Allawi H; Yab TC; Taylor WR; Simonson JA; Devens M; Heigh RI; Ahlquist DA; Berger BM
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1313-8. PubMed ID: 23639600
[TBL] [Abstract][Full Text] [Related]
40. Impact of screening and follow-up colonoscopy adenoma sensitivity on colorectal cancer screening outcomes in the CRC-AIM microsimulation model.
Fisher DA; Saoud L; Hassmiller Lich K; Fendrick AM; Ozbay AB; Borah BJ; Matney M; Parton M; Limburg PJ
Cancer Med; 2021 Apr; 10(8):2855-2864. PubMed ID: 33314646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]